IL6 and congenital rubella syndrome: ,48,49 CAR/CCR T cell-mediated release of IL-6, a major mediator of life-threatening CRS and neurotoxicity, is also reduced compared with CAR (2nd Gen), potentially decreasing the severity of these toxicities and the need for therapeutic intervention.